Severe Acute Hepatitis B Treated with Entecavir

Severe Acute Hepatitis B Treated with Entecavir

Show other versions (1)

Hepatitis B virus (HBV) infection constitutes a serious global health problem. Nowadays there are divergent data regarding the use of antiviral drugs to treat acute hepatitis B. We present here a case of a 62-year-old man affected by severe acute hepatitis B with progressive worsening of clinical an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Giuseppe Vittorio Luigi De Socio, Alessio Sgrelli, Andrea Tosti, Franco Baldelli
Format:	Article
Language:	English
Published:	PAGEPress Publications 2011-03-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Acute Hepatitis B, Entecavir, HBV therapy
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/316
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Severe Acute Hepatitis B Treated with Entecavir
by: Andrea Tosti, et al.
Published: (2011-01-01)

Experience of entecavir in renal graft recipients with chronic hepatitis B
by: M. L. Zubkin, et al.
Published: (2011-09-01)

Adherence to entecavir for chronic hepatitis B and correlation with effectiveness
by: Vanessa Romero Díaz-Maroto, et al.
Published: (2015-11-01)

Long-term efficacy and safety of tenofovir alafenamide, tenofovir disoproxil fumarate, and entecavir in treating hepatitis B virus-related acute-on-chronic liver failure: A 144-week data analysis
by: Yeqiong Zhang, et al.
Published: (2024-12-01)

Validation of quantitative hepatitis B virus DNA and hepatitis B e antigen titers in patients of chronic hepatitis B virus infection on entecavir therapy at tertiary care hospital
by: Diksha Budhani, et al.
Published: (2025-01-01)

Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis B
by: Takuya Matsubara, et al.
Published: (2025-01-01)

Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis
by: Lu Cao, et al.
Published: (2025-01-01)

A Sleeping Giant: Late HBV Reactivation After Rituximab-Based Chemotherapy Despite Correct Prophylaxis
by: Nowicka AA, et al.
Published: (2024-12-01)

Switching to Tenofovir Therapy Versus Continuation of Entecavir for Patients With Hepatitis B Virus Infection: A Systematic Review and Meta‐Analysis
by: Muhammad Shahzil, et al.
Published: (2024-11-01)

Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B
by: Beatriz López Centeno, et al.
Published: (2016-07-01)

Challenges in the Treatment of Acute Fulminant Hepatitis B: Case Report and Literature Review
by: Ali Alawieh, et al.
Published: (2014-08-01)

Chronic glomerulonephritis of the mixed type in patient with HBV-infection (<i>Clinical case</i>)
by: V. S. Adonyeva, et al.
Published: (2013-07-01)

Bibliometric analysis of entecavir for the treatment of cirrhosis in hepatitis B
by: Yu Zhang, et al.
Published: (2024-12-01)

Characterization of Hepatitis B Virus Transcripts in Chronically HBV-Infected Chimpanzees and Patients Treated with ARC-520 siRNA Demonstrates Transcriptional Silencing of cccDNA
by: Christine I. Wooddell, et al.
Published: (2024-12-01)

The dynamics of a delay model of hepatitis B virus infection with logistic hepatocyte growth
by: Steffen Eikenberry, et al.
Published: (2009-02-01)

Entecavir: stability and drug-excipient compatibility
by: Ariadne Botto Fiorot, et al.
Published: (2025-01-01)

Hepatitis B vertical transfer and its risk factors in pregnant women in the eastern part of Iran
by: M.N. Moghadam, et al.
Published: (2022-03-01)

Evaluation of genotype characteristics and drug resistance mutations in patients with chronic hepatitis B
by: Changlong He, et al.
Published: (2024-11-01)

Immune response to occult hepatitis B virus infection among hemodialysis patients: A review
by: Ali Mussa, et al.
Published: (2024-12-01)

Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis
by: Yi-Jie Huang, et al.
Published: (2025-01-01)

The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
by: Ling Ding, et al.
Published: (2025-12-01)

Seroprevalence of hepatitis B among the general population in Shandong Province, Eastern China, an update 30 years after the implementation of the neonatal vaccination program
by: Bingyu Yan, et al.
Published: (2024-12-01)

Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B
by: Qianqian Ma, et al.
Published: (2025-02-01)

Hepatitis B prevalence in an endemic area of hepatitis C virus: A population-based study implicated in hepatitis elimination in Thailand
by: Nawarat Posuwan, et al.
Published: (2024-12-01)

Intrahepatic Exhausted Antiviral Immunity in an Immunocompetent Mouse Model of Chronic Hepatitis BSummary
by: Satoshi Shigeno, et al.
Published: (2025-01-01)

Evaluation of Interfering RNA Efficacy in Treating Hepatitis B: Is It Promising?
by: Giovana Paula Angelice, et al.
Published: (2024-10-01)

Resolved Hepatitis B: Achieved or Imaginary Wellbeing?
by: S. N. Batskikh
Published: (2021-04-01)

Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma
by: Yaqin Zhang, et al.
Published: (2024-12-01)

Significant reduction in Hepatitis B virus infections following 32 years of universal Hepatitis B vaccination as part of EPI, Thailand
by: Pornjarim Nilyanimit, et al.
Published: (2025-01-01)

Limited stability of Hepatitis B virus RNA in plasma and serum
by: Valerie Ohlendorf, et al.
Published: (2024-11-01)

Association between intrahepatic cccDNA and the severity of liver inflammation in chronic hepatitis B virus infection patients
by: Suxian Zhao, et al.
Published: (2025-01-01)

Association between Hepatitis B virus infection and COVID-19: outcomes from clinical analysis and online survey from Beijing, China
by: Fei Lin, et al.
Published: (2024-12-01)

Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B
by: Wei He, et al.
Published: (2024-12-01)

PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN
by: Anil Pathare, et al.
Published: (2019-10-01)

Removal of the Active Pharmaceutical Substance Entecavir from Water via the Fenton Reaction or Action by the Cyanobacterium <i>Microcystis novacekii</i>
by: Cléssius Ribeiro de Souza, et al.
Published: (2024-12-01)

Anti-HBs Positivity Related to Past HBV Infection and Vaccination in Older Adults in Polish Population—Cohort-Based Study
by: Katarzyna Zięba, et al.
Published: (2024-12-01)

Comparative evaluation of APRI and MELD scores in the prediction of complications of chronic hepatitis in patients infected with hepatitis B or C viruses in Lubumbashi, democratic republic of Congo
by: Arsène Kabamba-Tshikongo, et al.
Published: (2025-02-01)

Evaluation of the acute hepatitis B surveillance system in the Republic of Korea following the transition to mandatory surveillance
by: Jaehwa Chung, et al.
Published: (2024-08-01)

Cholesterol metabolism regulator SREBP2 inhibits HBV replication via suppression of HBx nuclear translocation
by: Fan Yang, et al.
Published: (2025-01-01)

Protracted HBsAg-aemia in a Patient with Acute Hepatitis B
by: K. R. Dudina, et al.
Published: (2018-11-01)